Net Income
Net Income
Neurocrine Biosciences Net Income increased by 28.8% to $197.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2405.1%, from $7.90M to $197.90M. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 49.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.30M | $22.50M | $0.00 | $13.90M | -$16.90M | $68.50M | $89.00M | -$76.60M | $95.50M | $83.10M | $147.70M | $43.40M | $65.00M | $129.80M | $103.10M | $7.90M | $107.50M | $209.50M | $153.70M | $197.90M |
| QoQ Change | — | -46.8% | -100.0% | — | -221.6% | +505.3% | +29.9% | -186.1% | +224.7% | -13.0% | +77.7% | -70.6% | +49.8% | +99.7% | -20.6% | -92.3% | >999% | +94.9% | -26.6% | +28.8% |
| YoY Change | — | — | — | — | -140.0% | +204.4% | — | -651.1% | +665.1% | +21.3% | +66.0% | +156.7% | -31.9% | +56.2% | -30.2% | -81.8% | +65.4% | +61.4% | +49.1% | >999% |
Range-$76.60M – $209.50M
CAGR+38.4%
Avg YoY Growth+187.7%
Median YoY Growth+56.2%
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $7.90M | $107.50M | $209.50M | $153.70M | $197.90M |
| Total | $7.90M | $107.50M | $209.50M | $153.70M | $197.90M |
Net Income at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's net income?
- Neurocrine Biosciences (NBIX) reported net income of $197.90M in Q1 2026.
- How has Neurocrine Biosciences's net income changed year-over-year?
- Neurocrine Biosciences's net income increased by 2405.1% year-over-year, from $7.90M to $197.90M.
- What is the long-term trend for Neurocrine Biosciences's net income?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's net income has grown at a 49.1% compound annual growth rate (CAGR), from $96.90M to $478.60M.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.